Bioxyne Ltd (BXN) — Capital Reinvestment Ratio
Latest as of June 2025:
0.33x
Bioxyne Ltd (BXN) has a Capital Reinvestment Ratio of 0.33x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$3.32 Million) in capital expenditures (AU$1.11 Million). See BXN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.33x
Capex / Operating Cash Flow
Operating Cash Flow
AU$3.32 Million
AUD
Capital Expenditures
AU$1.11 Million
AUD
Data as of
Jun 2025
Most recent filing
Bioxyne Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Bioxyne Ltd's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Bioxyne Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Bioxyne Ltd from 2014 to 2025. For live market cap and broader valuation context, see market cap of Bioxyne Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | AU$6.28 Million | AU$2.41 Million | ▼ -39.3% |
| 2021 | 0.63x | AU$53.13K | AU$33.66K | ▼ -9.2% |
| 2020 | 0.70x | AU$48.25K | AU$33.66K | ▲ +6108.8% |
| 2016 | 0.01x | AU$348.85K | AU$3.92K | ▲ +73.9% |
| 2014 | 0.01x | AU$606.76K | AU$3.92K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow